Skip to main content
CriticalFDAfda-F-1743-2017OTHER

DH. ANCHOVY 2.2 Lbs.; Item No: D0161; B/C: 59033 50161; DH. ANCHOVY 3.5 oz..; Item No: D0162; B/C: 59033 50162

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (other). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
490
Recall Date
October 21, 2015
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1743-2017.

Product may have the potential for pathogen growth and toxin formation due to Clostridium botulinum.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1743-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Seafood Avenue or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1743-2017.

Seafood Avenue

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Seafood Avenue Recall FAQ

Seafood Avenue is the subject of a food safety report: DH. ANCHOVY 2.2 Lbs.; Item No: D0161; B/C: 59033 50161; DH. ANCHOVY 3.5 oz..; Item No: D0162; B/C: 59033 50162. The notice was published on October 21, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 490 units are potentially affected.